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Srinivasan et al., page 167
Ask any expectant parents what they most hope for, and
the answer invariably will be ‘‘a healthy baby.’’ Fortunately
for most, healthy is the outcome. However, during the
course of embryonic development, things can, and do,
go wrong. To prepare parents for such an outcome, there
exist a variety of testing options, both noninvasive (e.g.,
sonography) and invasive (e.g., amniocentesis and cho-
rionic villus sampling). However, the more sensitive inva-
sive tests carry a risk of harm to the fetus and are therefore
used only when medically indicated and must be per-
formed by a doctor with specialized training. In recent
years, it has become clear that fetal DNA is present and
detectable in maternal blood, and tests have been devel-
oped to detect certain common chromosomal abnormali-
ties, such as trisomy 21. Now, Srinivasan et al. report on
the use of next-generation sequencing for detecting nearly
any chromosomal abnormality with the same accuracy as
the more invasive procedures. This report suggests that
a new standard of care in obstetrics is within sight: one
that eliminates unnecessary risks while providing doctors
and their patients the information needed for the proper
management of both high- and low-risk pregnancies.Harnessing Pleiotropy to Improve Variant
Discovery
Andreassen et al., page 197
Genome-wide association studies havebeenuseful for iden-
tifying variants that contribute to complex human traits.
There are, however, limitations to these studies: oftentimes,
the contribution by an individual SNP does not reach
genome-wide significance. Because some genes, and pre-
sumably certain SNPs within those genes, influence mul-
tiple traits, using a pleiotropy-informed approach might
allow for capture of these SNPs. For example, evidence
suggests that schizophrenic individuals have a higher
incidence of cardiovascular-disease (CVD) risk factors, indi-
cating that there might be some shared genetic contribu-
tion to both diseases. Rather than look for SNPs that reach
significance for schizophrenia and CVD risk factors inde-
pendently, Andreassen et al. used a combined analysis
to identify SNPs that reach genome-wide significance for
schizophrenia. When they used a stratified conditional-1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The AmericFDR (false discovery rate) approach, they identified 25
significant loci; notably, nine of these loci had been
previously identified as being associated with schizo-
phrenia. Without the combined analysis, only five sig-
nificant loci were identified. These results hint that there
might be an underlying shared biological network that
affects both schizophrenia andCVDor that the twodiseases
share risk factors. This approach demonstrates the feasi-
bility of combining variants from shared risk factors to
improve the identification of significant SNPs. Perhaps
the combined analysis of other comorbidities will uncover
more of the ‘‘missing heritability.’’Zooming In on Autism CNVs
Girirajan et al., page 221
Recent studies point to a connection between overall
burden of copy-number variants (CNVs) and decreased
cognitive ability.However, it has remainedunclearwhether
these CNVs specify susceptibility to distinct neurodevelop-
mental defects. In this issue, Girirajan et al. approach this
question, specifically with respect to autism spectrum
disorder (ASD), through the studyof genomic regionsprone
to recurrent rearrangements, i.e., hotspots. The authors
designed a custom microarray to interrogate these regions,
and such an approach will no doubt be useful in studies of
other diseases associated with complex genomic architec-
ture. Their work shows that, across the genome, mutability
depends on both the sequence of the affected region and
the nature of the flanking repetitive sequences. In agree-
ment with previous results, they found an excess of large
deletions in a cohort of individuals with ASD; however,
they did not find any deletions specific to ASD (and
not intellectual disability). By contrast, smaller deletions
showed no association with autism phenotypes. Larger
deletions, of course, affect a larger number of genes, and
so further research will be needed for better understanding
these observations. The integrationof data from studies like
this with ongoing large-scale sequencing projects should
help to answermany of the lingering questions in this field.Flip-flops and the ‘‘Polynesian Motif’’
Duggan and Stoneking, page 279
Mitochondrial haplotypes are useful for mapping hu-
man evolutionary history and are defined by a set ofy of Human Genetics. All rights reserved.
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mtDNA base-pair changes. One such transition,
m.16247A>G, defines the B4a1a1a haplogroup, com-
monly known as the ‘‘Polynesian motif,’’ and is used as
an Oceanic marker associated with the Austronesian
expansion. This transition should also be present in
sublineages such as B4a1a1a1. However, in evaluating
536 complete mtDNA sequences of the B4a1a1a1 haplo-
type, Duggan and Stoneking found that approximately
20% of these individuals did not carry the immediate
G ancestral allele that identifies the Polynesian motif.
Several lines of evidence, such as the rate of back
mutation, levels of heteroplasmy, and the time frame
in which the allele and the back mutations arose
(only 7,200 years ago), have suggested that the G allele
is unstable. In fact, the G allele appears to slightly desta-
bilize the mtDNA structure, which might explain
the variant’s tendency toward reversion. Although the
extent of mtDNA mutations that define a haplotype
and that are prone to reversion in such short evolu-
tionary time frames is currently unclear, these findings
underline the value of whole-genome sequencing for
haplotyping.164 The American Journal of Human Genetics 92, 163–164, FebruaryMystery of Y-Linked Hearing Impairment Is
Untangled
Wang et al., page 301
For years, the search for Y-linked Mendelian disorders has
intrigued geneticists despite the fact that many traits previ-
ously ascribed to the Y chromosome, such as ‘‘hairy ears,’’
have not withstood the test of time. However, the causal
mutation of DFNY1, a bona fide Y-linked locus associated
with hearing impairment, has remained a mystery. In
this study, Wang et al. identified an insertion in the Y
chromosome of men with Y-linked hearing impairment.
Interestingly, this insertion contains DNFA49, a chromo-
some 1 locus that was previously associated with hearing
impairment. This work suggests that the genetic basis of
hearing loss for both loci—DFNY1 on the Y chromosome
and DNFA49 on chromosome 1—might be caused
by mutations in a gene residing on chromosome 1 rather
than by a mutation in a Y chromosome gene. Although
the mystery of Y-linked hearing impairment in DFNY1
has been cracked, the search for Y chromosome mutations
causing inherited disorders continues.7, 2013
